Aaron Logan, MD, PhD
Biography Stanford University | Blood and Marrow Transplantation | 2012 | Medicine | Stanford University | Hematology | 2009 | Medicine | Stanford University | Internal Medicine (Internship and Residency) | 2008 | Clinical Investigator Pathway | University of Southern California | M.D. | 2006 | Keck School of Medicine | University of Southern California | Ph.D. (Molec Microbio and Immunology) | 2006 | Keck School of Medicine | University of Cambridge, England | M.Phil. | 1997 | History and Philosophy of Medicine |
Overview Dr. Aaron Logan is an Associate Professor of Clinical Medicine at the University of California, San Francisco (UCSF). His clinical practice focuses on the management of patients with acute leukemias, myelodysplastic syndrome, aplastic anemia and hemophagocytic lymphohistiocytosis. Dr. Logan also runs a research laboratory and is director of the Hematologic Malignancies Tissue Bank at UCSF. Dr. Logan and his laboratory are interested in methods for evaluating clonotypic diversity in the B and T lymphocyte repertoires in patients, particularly following hematopoietic cell transplantation when used to treat blood cancers, bone marrow failure disorders, and congenital immune deficiencies. Methods used in the laboratory currently include T cell receptor excision circle and kappa-deleting recombination circle (TREC/KREC) quantification, high-throughput sequencing of immunoglobulin and T cell receptor genes, and in vitro mixed lymphocyte reactions to identify T cells with specific reactivities. Efforts in the lab are focused on the application of immune repertoire profiling to quantify and track malignancy-, pathogen-, and autoantigen-targeted immune responses following allogeneic transplantation, as well as use of this platform to quantify measurable residual disease in lymphoid malignancies. In Dr. Logan’s lab, the Hematologic Malignancies Tissue Bank at UCSF has been built into a robust resource for samples isolated from patients with a wide diversity of blood cancers and following transplantation. These samples are made available in a deidentified manner to the UCSF and larger research community for cooperative discovery.
The phone number listed above is Dr. Logan's direct office number.
If you prefer to contact the outpatient clinic, please call 415-353-2421.
The clinic fax number is 415-353-2467.
hematology, blood and marrow transplantation (BMT), hematopoietic stem cell transplantation, hematopoietic stem and progenitor cell biology, graft versus host disease, measurable residual disease, minimal residual disease, leukemia, acute myelogenous leukemia (AML), acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), myelodysplastic syndrome (MDS), hemophagocytic lymphohistiocytosis (HLH), aplastic anemia, lymphoma, myeloma, immunology, immune reconstitution, high-throughput sequencing, next generation sequencing, immunoreceptor sequencing, antibody-mediated conditioning
ORNG Applications Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Serial comprehensive geriatric and quality of life assessments in adults age = 50 years undergoing autologous hematopoietic cell transplantation. J Geriatr Oncol. 2020 Oct 13.
Nawas MT, Sheng Y, Huang CY, Andreadis C, Martin TG, Wolf JL, Ai WZ, Kaplan LD, Mannis GN, Logan AC, Damon LE, Olin RL. PMID: 33059999.
View in: PubMed Mentions: Fields:
-
Clinical Significance and Management of MRD in Adults With Acute Lymphoblastic Leukemia. Clin Adv Hematol Oncol. 2020 Jul; 18(7):413-422.
Akabane H, Logan A. PMID: 32903253.
View in: PubMed Mentions: Fields:
-
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation. Antimicrob Agents Chemother. 2020 03 24; 64(4).
Maertens J, Logan AC, Jang J, Long G, Tang JL, Hwang WYK, Koh LP, Chemaly R, Gerbitz A, Winkler J, Yeh SP, Hiemenz J, Christoph S, Lee DG, Wang PN, Holler E, Mielke S, Akard L, Yeo A, Ramachandra S, Smith K, Pertel P, Segal F. PMID: 32015031.
View in: PubMed Mentions: Fields:
-
Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients. Biol Blood Marrow Transplant. 2020 01; 26(1):189-196.
Huang LW, Sheng Y, Andreadis C, Logan AC, Mannis GN, Smith CC, Gaensler KML, Martin TG, Damon LE, Steinman MA, Huang CY, Olin RL. PMID: 31493541.
View in: PubMed Mentions: 4 Fields:
-
Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study. Biol Blood Marrow Transplant. 2019 10; 25(10):2002-2007.
Waller EK, Miklos D, Cutler C, Arora M, Jagasia MH, Pusic I, Flowers MED, Logan AC, Nakamura R, Chang S, Clow F, Lal ID, Styles L, Jaglowski S. PMID: 31260802.
View in: PubMed Mentions: 2 Fields: Translation: HumansCTClinical Trials
-
Histone Deacetylase Inhibition with Panobinostat Combined with Intensive Induction Chemotherapy in Older Patients with Acute Myeloid Leukemia: Phase I Study Results. Clin Cancer Res. 2019 08 15; 25(16):4917-4923.
Wieduwilt MJ, Pawlowska N, Thomas S, Olin R, Logan AC, Damon LE, Martin T, Kang M, Sayre PH, Boyer W, Gaensler KML, Anderson K, Munster PN, Andreadis C. PMID: 31152020.
View in: PubMed Mentions: 5 Fields: Translation: HumansCellsCTClinical Trials
-
Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia. Cancer Discov. 2019 08; 9(8):1050-1063.
McMahon CM, Ferng T, Canaani J, Wang ES, Morrissette JJD, Eastburn DJ, Pellegrino M, Durruthy-Durruthy R, Watt CD, Asthana S, Lasater EA, DeFilippis R, Peretz CAC, McGary LHF, Deihimi S, Logan AC, Luger SM, Shah NP, Carroll M, Smith CC, Perl AE. PMID: 31088841.
View in: PubMed Mentions: 30 Fields: Translation: HumansCells
-
Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2019. J Natl Compr Canc Netw. 2019 05 01; 17(5):414-423.
Brown PA, Wieduwilt M, Logan A, DeAngelo DJ, Wang ES, Fathi A, Cassaday RD, Litzow M, Advani A, Aoun P, Bhatnagar B, Boyer MW, Bryan T, Burke PW, Coccia PF, Coutre SE, Jain N, Kirby S, Liu A, Massaro S, Mattison RJ, Oluwole O, Papadantonakis N, Park J, Rubnitz JE, Uy GL, Gregory KM, Ogba N, Shah B. PMID: 31085755.
View in: PubMed Mentions: 4 Fields: Translation: Humans
-
Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice. Blood. 2019 05 09; 133(19):2069-2078.
Pang WW, Czechowicz A, Logan AC, Bhardwaj R, Poyser J, Park CY, Weissman IL, Shizuru JA. PMID: 30745302.
View in: PubMed Mentions: 10 Fields: Translation: HumansAnimalsCells
-
Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 06; 25(6):1218-1224.
Nawas MT, Andreadis C, Martin TG, Wolf JL, Ai WZ, Kaplan LD, Mannis GN, Logan AC, Damon LE, Huang CY, Olin RL. PMID: 30708189.
View in: PubMed Mentions: 5 Fields: Translation: Humans
-
Anti-human CD117 antibody-mediated bone marrow niche clearance in nonhuman primates and humanized NSG mice. Blood. 2019 05 09; 133(19):2104-2108.
Kwon HS, Logan AC, Chhabra A, Pang WW, Czechowicz A, Tate K, Le A, Poyser J, Hollis R, Kelly BV, Kohn DB, Weissman IL, Prohaska SS, Shizuru JA. PMID: 30617195.
View in: PubMed Mentions: 8 Fields: Translation: HumansAnimalsCells
-
Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts. Am J Hematol. 2019 02; 94(2):257-265.
Short NJ, Jabbour E, Albitar M, de Lima M, Gore L, Jorgensen J, Logan AC, Park J, Ravandi F, Shah B, Radich J, Kantarjian H. PMID: 30394566.
View in: PubMed Mentions: 11 Fields: Translation: Humans
-
Plasma Cell-Free DNA Next-Generation Sequencing to Diagnose and Monitor Infections in Allogeneic Hematopoietic Stem Cell Transplant Patients. Open Forum Infect Dis. 2018 Dec; 5(12):ofy301.
Fung M, Zompi S, Seng H, Hollemon D, Parham A, Hong DK, Bercovici S, Dolan E, Lien K, Teraoka J, Logan AC, Chin-Hong P. PMID: 30581881.
View in: PubMed Mentions:
-
Breakthrough Invasive Fungal Infections on Isavuconazole Prophylaxis and Treatment: What Is Happening in the Real-World Setting? Clin Infect Dis. 2018 09 14; 67(7):1142-1143.
Fung M, Schwartz BS, Doernberg SB, Langelier C, Lo M, Graff L, Tan M, Logan AC, Chin-Hong P, Babik JM. PMID: 29617983.
View in: PubMed Mentions: 10 Fields: Translation: Humans
-
Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant. Case Rep Hematol. 2018; 2018:6092646.
Rahmat LT, Nguyen A, Abdulhaq H, Prakash S, Logan AC, Mannis GN. PMID: 30225152.
View in: PubMed Mentions:
-
Ibrutinib for the treatment of patients with chronic graft-versus-host disease after failure of one or more lines of systemic therapy. Drugs Today (Barc). 2018 May; 54(5):305-313.
Rahmat LT, Logan AC. PMID: 29911695.
View in: PubMed Mentions: Fields: Translation: HumansAnimals
-
Logan AC. Sequence-specific MRD for ALL, in: Emadi A and Karp JE (Eds). Acute Leukemia: an Illustrated Guide to Diagnosis and Treatment. Demos Medical, New York. 2018.
-
Hourigan CS and Logan AC. Measurable Residual Disease for AML, in: Emadi A and Karp JE (Eds). Acute Leukemia: an Illustrated Guide to Diagnosis and Treatment, Demos Medical, New York. 2018.
-
Using Social Media at National Meetings in Hematology-Optimal Use, Tips, Strategies, and Limitations. Curr Hematol Malig Rep. 2017 12; 12(6):605-610.
Logan AC. PMID: 29076056.
View in: PubMed Mentions: 3 Fields: Translation: Humans
-
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy. Blood. 2017 11 23; 130(21):2243-2250.
Miklos D, Cutler CS, Arora M, Waller EK, Jagasia M, Pusic I, Flowers ME, Logan AC, Nakamura R, Blazar BR, Li Y, Chang S, Lal I, Dubovsky J, James DF, Styles L, Jaglowski S. PMID: 28924018.
View in: PubMed Mentions: 37 Fields: Translation: HumansCTClinical Trials
-
Obinutuzumab-induced serum sickness following salvage therapy for chronic lymphocytic leukemia. Clin Case Rep. 2017 06; 5(6):891-893.
Saba J, Logan AC. PMID: 28588833.
View in: PubMed Mentions:
-
The clinical impact of cytomegalovirus infection following allogeneic hematopoietic cell transplantation: Why the quest for meaningful prophylaxis still matters. Blood Rev. 2017 05; 31(3):173-183.
Chan ST, Logan AC. PMID: 28173959.
View in: PubMed Mentions: 10 Fields: Translation: HumansCells
-
What the blood knows: interrogating circulating tumor DNA to predict progression of minimal residual disease in early breast cancer. Ann Transl Med. 2016 Dec; 4(24):543.
Majure M, Logan AC. PMID: 28149904.
View in: PubMed Mentions:
-
Acute Liver Failure Secondary to Hemophagocytic Lymphohistiocytosis during Pregnancy. ACG Case Rep J. 2016 Aug; 3(4):e162.
Giard JM, Decker KA, Lai JC, Gill RM, Logan AC, Fix OK. PMID: 27921061.
View in: PubMed Mentions:
-
Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016 12 01; 126(12):4640-4653.
Sherbenou DW, Aftab BT, Su Y, Behrens CR, Wiita A, Logan AC, Acosta-Alvear D, Hann BC, Walter P, Shuman MA, Wu X, Atkinson JP, Wolf JL, Martin TG, Liu B. PMID: 27841764.
View in: PubMed Mentions: 22 Fields: Translation: HumansAnimalsCells
-
Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT. Blood. 2016 12 22; 128(25):2899-2908.
Ryan CE, Sahaf B, Logan AC, O'Brien S, Byrd JC, Hillmen P, Brown JR, Dyer MJ, Mato AR, Keating MJ, Jaglowski S, Clow F, Rezvani AR, Styles L, Coutre SE, Miklos DB. PMID: 27802969.
View in: PubMed Mentions: 19 Fields: Translation: HumansCellsCTClinical Trials
-
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016 11; 22(11):1974-1982.
Mulé MP, Mannis GN, Wood BL, Radich JP, Hwang J, Ramos NR, Andreadis C, Damon L, Logan AC, Martin TG, Hourigan CS. PMID: 27544285.
View in: PubMed Mentions: 7 Fields: Translation: Humans
-
Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 06; 22(6):1030-1036.
Mannis GN, Martin TG, Damon LE, Andreadis C, Olin RL, Kong KA, Faham M, Hwang J, Ai WZ, Gaensler KML, Sayre PH, Wolf JL, Logan AC. PMID: 26899561.
View in: PubMed Mentions: 5 Fields: Translation: HumansCells
-
Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission. Leuk Lymphoma. 2016 07; 57(7):1560-6.
Mannis GN, Martin TG, Damon LE, Logan AC, Olin RL, Flanders MD, Ai WZ, Gaensler KM, Kaplan LD, Sayre PH, Smith CC, Wolf JL, Andreadis C. PMID: 26490487.
View in: PubMed Mentions: 2 Fields: Translation: Humans
-
Hematopoietic cell transplantation for chronic lymphocytic leukemia, in: Appelbaum FR, Forman SJ, Negrin RS, Antin JH (Eds). Thomas' Hematopoietic Cell Transplantation, 5th Ed, John Wiley & Sons, Ltd., Chichester, UK. 2015.
Logan AC, Miklos DB.
-
Narrowband UV-B Phototherapy for Steroid-Refractory Sclerotic Chronic Cutaneous Graft-vs-Host Disease. JAMA Dermatol. 2015 Jun; 151(6):635-7.
Sorenson E, McAndrew R, Patel V, Logan AC, Koo J, Levin E. PMID: 25806783.
View in: PubMed Mentions: 1 Fields: Translation: Humans
-
A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015 Jun; 15(6):377-83.
Mannis GN, Andreadis C, Logan AC, Damon LE, Benet LZ, Ai WZ, Gaensler KM, Kaplan LD, Koplowicz YB, Linker CA, Olin RL, Sayre PH, Smith CC, Sudhindra A, Venstrom JM, Wolf JL, Martin TG. PMID: 25776193.
View in: PubMed Mentions: 1 Fields: Translation: HumansCTClinical Trials
-
ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2015 Apr; 21(4):746-54.
Logan AC, Wang Z, Alimoghaddam K, Wong RM, Lai T, Negrin RS, Grumet C, Logan BR, Zhang MJ, Spellman SR, Lee SJ, Miklos DB. PMID: 25572032.
View in: PubMed Mentions: 10 Fields: Translation: HumansCTClinical Trials
-
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis. Bone Marrow Transplant. 2015 Jan; 50(1):40-4.
Mannis GN, Logan AC, Leavitt AD, Yanada M, Hwang J, Olin RL, Damon LE, Andreadis C, Ai WZ, Gaensler KM, Greene CC, Gupta NK, Kaplan LD, Mahindra A, Miyazaki Y, Naoe T, Ohtake S, Sayre PH, Smith CC, Venstrom JM, Wolf JL, Caballero L, Emi N, Martin TG. PMID: 25243620.
View in: PubMed Mentions: 3 Fields: Translation: HumansCTClinical Trials
-
Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2014 May 27; 111(21):E2219-28.
Kharabi Masouleh B, Geng H, Hurtz C, Chan LN, Logan AC, Chang MS, Huang C, Swaminathan S, Sun H, Paietta E, Melnick AM, Koeffler P, Müschen M. PMID: 24821775.
View in: PubMed Mentions: 33 Fields: Translation: HumansAnimalsCells
-
Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse and survival. Biol Blood Marrow Transplant. 2014 Sep; 20(9):1307-13.
Logan AC, Vashi N, Faham M, Carlton V, Kong K, Buño I, Zheng J, Moorhead M, Klinger M, Zhang B, Waqar A, Zehnder JL, Miklos DB. PMID: 24769317.
View in: PubMed Mentions: 34 Fields: Translation: Humans
-
Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia. Leukemia. 2013 Aug; 27(8):1659-65.
Logan AC, Zhang B, Narasimhan B, Carlton V, Zheng J, Moorhead M, Krampf MR, Jones CD, Waqar AN, Faham M, Zehnder JL, Miklos DB. PMID: 23419792.
View in: PubMed Mentions: 45 Fields: Translation: Humans
-
Hemophagocytic lymphohistiocytosis in pregnancy: a case report and review of treatment options. Hematology. 2012 Nov; 17(6):325-8.
Dunn T, Cho M, Medeiros B, Logan A, Ungewickell A, Liedtke M. PMID: 23168071.
View in: PubMed Mentions: 11 Fields: Translation: Humans
-
Cancer vaccines and T cell therapy. Biol Blood Marrow Transplant. 2013 Jan; 19(1 Suppl):S97-S101.
Rezvani K, Brody JD, Kohrt HE, Logan AC, Advani R, Czerwinski DK, Weng WK, Negrin RS, Carlton V, Faham M, Levy R, Barrett J. PMID: 23041602.
View in: PubMed Mentions: 2 Fields: Translation: HumansAnimalsCells
-
Accessory splenules in autoimmune hemolytic anemia. Am J Hematol. 2013 Feb; 88(2):156.
Logan A, Berube C, Gotlib J. PMID: 23027373.
View in: PubMed Mentions: Fields: Translation: Humans
-
The road to purified hematopoietic stem cell transplants is paved with antibodies. Curr Opin Immunol. 2012 Oct; 24(5):640-8.
Logan AC, Weissman IL, Shizuru JA. PMID: 22939368.
View in: PubMed Mentions: 8 Fields: Translation: HumansAnimalsCells
-
Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia. Blood. 2012 Nov 22; 120(22):4407-17.
Gawad C, Pepin F, Carlton VE, Klinger M, Logan AC, Miklos DB, Faham M, Dahl G, Lacayo N. PMID: 22932801.
View in: PubMed Mentions: 43 Fields: Translation: Humans
-
Maintenance bevacizumab is associated with increased hemoglobin in patients with advanced, nonsquamous, non-small cell lung cancer. Cancer Invest. 2012 Mar; 30(3):231-5.
Riess JW, Logan AC, Krupitskaya Y, Padda S, Clément-Duchêne C, Ganjoo K, Colevas AD, Pedro-Salcedo MS, Kuo CJ, Wakelee HA. PMID: 22360362.
View in: PubMed Mentions: 2 Fields: Translation: HumansCTClinical Trials
-
Acute lymphoblastic leukemia, in Clinical Decision Support: Hospital Medicine, edited by Wiese J, Auerbach A, Glasheen J, Li J. Decision Support in Medicine, LLC. Wilmington, DE. 2012.
Malik UF, Dastaghyab N, Logan AC. .
-
High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment. Proc Natl Acad Sci U S A. 2011 Dec 27; 108(52):21194-9.
Logan AC, Gao H, Wang C, Sahaf B, Jones CD, Marshall EL, Buño I, Armstrong R, Fire AZ, Weinberg KI, Mindrinos M, Zehnder JL, Boyd SD, Xiao W, Davis RW, Miklos DB. PMID: 22160699.
View in: PubMed Mentions: 55 Fields: Translation: HumansPHPublic Health
-
Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med. 2011 Apr 19; 154(8):529-40.
Yank V, Tuohy CV, Logan AC, Bravata DM, Staudenmayer K, Eisenhut R, Sundaram V, McMahon D, Olkin I, McDonald KM, Owens DK, Stafford RS. PMID: 21502651.
View in: PubMed Mentions: 51 Fields: Translation: Humans
-
Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records. Ann Intern Med. 2011 Apr 19; 154(8):516-22.
Logan AC, Yank V, Stafford RS. PMID: 21502649.
View in: PubMed Mentions: 28 Fields: Translation: Humans
-
Rockville (MD): Agency for Healthcare Research and Quality (US); 2010 May. Report No.: 10-EHC030-EF. Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs. Usual Care. 2010.
Yank V, Tuohy CV, Logan AC, Bravata DM, Staudenmayer K, Eisenhut R, Sundaram V, McMahon D, Stave CD, Zehnder JL, Olkin I, McDonald KM, Owens DK, Stafford RS. View Publication.
-
Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting. Hematology Am Soc Hematol Educ Program. 2010; 2010:153-9.
Logan AC, Goodnough LT. PMID: 21239786.
View in: PubMed Mentions: 6 Fields: Translation: Humans
-
Reversible high-output cardiac failure, an unusual marker of disease status in multiple myeloma. Leuk Lymphoma. 2008 Mar; 49(3):581-5.
Kohrt H, Logan A, Temmins C, Witteles R, Liedtke M, Medeiros B. PMID: 18297538.
View in: PubMed Mentions: Fields: Translation: Humans
-
Factors influencing the titer and infectivity of lentiviral vectors. Hum Gene Ther. 2004 Oct; 15(10):976-88.
Logan AC, Nightingale SJ, Haas DL, Cho GJ, Pepper KA, Kohn DB. PMID: 15585113.
View in: PubMed Mentions: 32 Fields: Translation: HumansCells
-
Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration. J Virol. 2004 Aug; 78(16):8421-36.
Logan AC, Haas DL, Kafri T, Kohn DB. PMID: 15280451.
View in: PubMed Mentions: 24 Fields: Translation: HumansCells
-
The Moloney murine leukemia virus repressor binding site represses expression in murine and human hematopoietic stem cells. J Virol. 2003 Sep; 77(17):9439-50.
Haas DL, Lutzko C, Logan AC, Cho GJ, Skelton D, Jin Yu X, Pepper KA, Kohn DB. PMID: 12915559.
View in: PubMed Mentions: 15 Fields: Translation: HumansAnimalsCells
-
Advances in lentiviral vector design for gene-modification of hematopoietic stem cells. Curr Opin Biotechnol. 2002 Oct; 13(5):429-36.
Logan AC, Lutzko C, Kohn DB. PMID: 12459333.
View in: PubMed Mentions: 19 Fields: Translation: HumansAnimalsCells
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
Year | Publications |
---|
2002 | 1 | 2003 | 1 | 2004 | 2 | 2008 | 1 | 2010 | 2 | 2011 | 3 | 2012 | 7 | 2013 | 1 | 2014 | 3 | 2015 | 4 | 2016 | 7 | 2017 | 4 | 2018 | 7 | 2019 | 8 | 2020 | 3 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People in Profiles who have published with this person.
_
People who share similar concepts with this person.
_
Search Department
_
|